| NCT ID | NCT06553261 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Barmherzige Brüder Vienna |
| Condition | Anastomotic Leak |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,446 participants |
| Start Date | 2024-08-12 |
| Primary Completion | 2024-10-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,446 participants in total. It began in 2024-08-12 with a primary completion date of 2024-10-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Data of patients undergoing elective right colectomy for benign and malignant disease using an open or laparoscopic approach are to be collected in seven colorectal units among Austria for the period between January 2010 and December 2019. Demographic, peri- and postoperative data of patients were analyzed retrospectively.
Eligibility Criteria
Inclusion Criteria: * Patients with benign or malignant diseases in the right portion of the colon. * elective surgery Exclusion Criteria: * emergent surgery
Contact & Investigator
Bernhard Dauser, Assoc. Prof.
PRINCIPAL INVESTIGATOR
Krankenhaus der Barmherzigen Brüder Vienna
Frequently Asked Questions
Who can join the NCT06553261 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anastomotic Leak. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06553261 currently recruiting?
Yes, NCT06553261 is actively recruiting participants. Contact the research team at bernhard.dauser@gmail.com for enrollment information.
Where is the NCT06553261 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT06553261 clinical trial?
NCT06553261 is sponsored by Barmherzige Brüder Vienna. The principal investigator is Bernhard Dauser, Assoc. Prof. at Krankenhaus der Barmherzigen Brüder Vienna. The trial plans to enroll 3,446 participants.